Taken together, our data suggest that higher POSTN expression is associated with higher stromal infiltration and enhanced immune‐suppressive condition in the tumor microenvironment, potentially attenuating immunotherapy efficacy in pancreatic cancer patients. This evidence concerns the gene POSTN and neoplasm.